Sept. 3 Company Quick Takes: Mundipharma-Cidara, Roche-Spark, Vascepa

Mundipharma licenses rights to Cidara’s rezafungin
Cidara Therapeutics Inc. (NASDAQ:CDTX) granted Mundipharma International Ltd. (Dublin, Ireland) exclusive rights to develop and commercialize rezafungin

Read the full 223 word article

User Sign In